Evidence report: the medical treatment of ocular myasthenia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
about
Evaluation of the quality of guidelines for myasthenia gravis with the AGREE II instrumentPrecision medicine in myasthenia graves: begin from the data precisionSurgical treatment for medically refractory myasthenic blepharoptosis.The anti-acetylcholine receptor antibody test in suspected ocular myasthenia gravis.Current and emerging therapies for the treatment of myasthenia gravis.Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot study.An up-date on health-related quality of life in myasthenia gravis -results from population based cohortsSafety of prednisone for ocular myasthenia gravis.Immunosuppressive therapies in myasthenia gravis.Glucocorticoids in myasthenia gravis - if, when, how, and how much?A Case Report of Congenital Fiber Type Disproportion with an Increased Level of Anti-ACh Receptor Antibodies.The effect of early prednisolone treatment on the generalization rate in ocular myasthenia gravis.Treatment of ocular myasthenia gravis.Tacrolimus monotherapy: a promising option for ocular myasthenia gravis.Ocular presentation of myasthenia gravis: A natural history cohort.Prognostic factors and health-related quality of life in ocular Myasthenia Gravis (OMG).Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial.Paraneoplastic syndromes of the neuromuscular junction: therapeutic options in myasthenia gravis, lambert-eaton myasthenic syndrome, and neuromyotonia.Is Surgical Intervention Safe and Effective in the Treatment of Myasthenic Blepharoptosis? A Multicenter Survey in JapanTopical naphazoline in the treatment of myasthenic blepharoptosis
P2860
Q21131900-B86D357F-77AB-48CE-A191-C201B609FFE5Q26748943-EA4EED1C-C2B9-4EE4-990E-AC2A09BE6E8DQ34265890-DD3773F2-B71E-4FE3-8386-B5ACFAB3FD6AQ34588412-B4EEEEB6-3349-4B1A-AE77-B74FD9CC7791Q34879129-868ED31D-6300-4932-A964-E149D952DBE9Q35877852-C70DA1E2-8D15-4442-A463-18BF5D28AFD1Q35908237-32D651EF-F111-459E-ADCC-531C02B64D60Q37063766-D9692472-2F97-4ED8-8FE8-AAF40B74569BQ37694576-8B4C84E7-0D27-4404-A15B-A22380C91BC7Q38234725-7B6B384D-D784-428C-A4D6-5F9EB8445DACQ41429301-812AA261-9A0B-470B-AF19-201D3F028055Q44046461-11EFCC96-CDA0-481D-9543-3A99EBD372F6Q44970301-1D8C854D-459A-468F-8DEB-AAF314592796Q45747372-4648732C-58F5-40E4-A5D5-F7BD0AC1AC46Q48020624-6DFDE751-9DA1-4148-BDAA-49AD64792EF4Q48135299-935E38E1-88DE-48B5-923A-E706B3BB0682Q50954321-4FCAEB4B-4F86-49DC-BE81-347ACE5539AFQ53118752-6626BC08-99EB-44DE-9FC0-D693A5994263Q58047406-A38E1C36-1C2F-4F65-9FEE-13427308A028Q58047503-4C37F250-D539-4E6C-928C-7CB17DD41F0B
P2860
Evidence report: the medical treatment of ocular myasthenia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Evidence report: the medical t ...... American Academy of Neurology.
@ast
Evidence report: the medical t ...... American Academy of Neurology.
@en
type
label
Evidence report: the medical t ...... American Academy of Neurology.
@ast
Evidence report: the medical t ...... American Academy of Neurology.
@en
prefLabel
Evidence report: the medical t ...... American Academy of Neurology.
@ast
Evidence report: the medical t ...... American Academy of Neurology.
@en
P1433
P1476
Evidence report: the medical t ...... American Academy of Neurology.
@en
P2093
Henry J Kaminski
Quality Standards Subcommittee of the American Academy of Neurology
P304
P356
10.1212/01.WNL.0000263481.14289.90
P407
P577
2007-04-25T00:00:00Z